|
FNTA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.456200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.366500E-04 |
| Normal-vs-Stage2 |
4.959000E-01 |
| Normal-vs-Stage3 |
2.302000E-02 |
| Normal-vs-Stage4 |
1.099760E-01 |
| Stage1-vs-Stage2 |
1.184610E-01 |
| Stage1-vs-Stage3 |
4.890600E-01 |
| Stage1-vs-Stage4 |
1.282230E-01 |
| Stage2-vs-Stage3 |
3.190000E-01 |
| Stage2-vs-Stage4 |
6.430800E-01 |
| Stage3-vs-Stage4 |
4.949800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.140700E-03 |
| Normal-vs-AfricanAmerican |
2.222200E-01 |
| Normal-vs-Asian |
1.033820E-04 |
| Caucasian-vs-AfricanAmerican |
8.463200E-01 |
| Caucasian-vs-Asian |
7.101800E-02 |
| AfricanAmerican-vs-Asian |
1.440600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.059500E-03 |
| Normal-vs-Female |
2.743500E-03 |
| Male-vs-Female |
8.033800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.396580E-03 |
| Normal-vs-Age(41-60Yrs) |
2.459600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.084000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.884210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.954000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.242200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.354800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.500200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.425800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.768000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.890000E-01 |
| Classical-VS-Follicular |
2.597100E-03 |
| Classical-VS-Other |
7.766800E-01 |
| Classical-VS-Normal |
5.62610000000019E-05 |
| Tall-VS-Follicular |
2.023000E-01 |
| Tall-VS-Other |
6.516400E-01 |
| Tall-VS-Normal |
7.853500E-02 |
| Follicular-VS-Other |
1.939600E-01 |
| Follicular-VS-Normal |
7.959600E-01 |
| Other-VS-Normal |
3.414000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.756100E-02 |
| Normal-vs-N1 |
5.825800E-02 |
| N0-vs-N1 |
8.623000E-01 |
|
|
